Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species

被引:409
作者
Bashan, Nava [1 ]
Kovsan, Julia
Kachko, Ilana
Ovadia, Hilla
Rudich, Assaf
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Fac Hlth Sci, Nutr Ctr, IL-84103 Beer Sheva, Israel
基金
以色列科学基金会;
关键词
NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; VASCULAR SMOOTH-MUSCLE; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; INCREASED OXIDATIVE STRESS; ACID-BINDING PROTEIN; HYDROGEN-PEROXIDE PRODUCTION; DEPENDENT DIABETES-MELLITUS; RECEPTOR SUBSTRATE-1 IRS-1;
D O I
10.1152/physrev.00014.2008
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A. Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species. Physiol Rev 89: 27-71, 2009; doi:10.1152/physrev.00014.2008. Regulated production of reactive oxygen species (ROS)/reactive nitrogen species (RNS) adequately balanced by antioxidant systems is a prerequisite for the participation of these active substances in physiological processes, including insulin action. Yet, increasing evidence implicates ROS and RNS as negative regulators of insulin signaling, rendering them putative mediators in the development of insulin resistance, a common endocrine abnormality that accompanies obesity and is a risk factor of type 2 diabetes. This review deals with this dual, seemingly contradictory, function of ROS and RNS in regulating insulin action: the major processes for ROS and RNS generation and detoxification are presented, and a critical review of the evidence that they participate in the positive and negative regulation of insulin action is provided. The cellular and molecular mechanisms by which ROS and RNS are thought to participate in normal insulin action and in the induction of insulin resistance are then described. Finally, we explore the potential usefulness and the challenges in modulating the oxidant-antioxidant balance as a potentially promising, but currently disappointing, means of improving insulin action in insulin resistance-associated conditions, leading causes of human morbidity and mortality of our era.
引用
收藏
页码:27 / 71
页数:45
相关论文
共 478 条
[1]   Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver [J].
Abel, ED ;
Peroni, O ;
Kim, JK ;
Kim, YB ;
Boss, O ;
Hadro, E ;
Minnemann, T ;
Shulman, GI ;
Kahn, BB .
NATURE, 2001, 409 (6821) :729-733
[2]   Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients [J].
Adachi, T ;
Inoue, M ;
Hara, H ;
Maehata, E ;
Suzuki, S .
JOURNAL OF ENDOCRINOLOGY, 2004, 181 (03) :413-417
[3]   The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].
Aguirre, V ;
Uchida, T ;
Yenush, L ;
Davis, R ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054
[4]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[5]   Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE):: LC-ESI-MS/MS evidence for Cys374 Michael adduction [J].
Aldini, G ;
Dalle-Donne, I ;
Vistoli, G ;
Facino, RM ;
Carini, M .
JOURNAL OF MASS SPECTROMETRY, 2005, 40 (07) :946-954
[6]   POLYMORPHONUCLEAR LEUKOCYTES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - ABNORMALITIES IN METABOLISM AND FUNCTION [J].
ALEXIEWICZ, JM ;
KUMAR, D ;
SMOGORZEWSKI, M ;
KLIN, M ;
MASSRY, SG .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (12) :919-+
[7]   MITOCHONDRIAL DECAY IN AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1271 (01) :165-170
[8]  
[Anonymous], 2007, DIABETES CARE, V30, pS48, DOI DOI 10.2337/DC07-S048
[9]   Antioxidant tempol lowers age-related increases in insulin resistance in Fischer 344 rats [J].
Asghar, Mohammad ;
Lokhandwala, Mustafa F. .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2006, 28 (05) :533-541
[10]  
Atabek ME, 2004, J PEDIATR ENDOCR MET, V17, P1063